Loading...
Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death
Drug combinations have been increasingly applied in chemotherapy as a strategy to enhance the efficacy of anti-cancer treatment. The appropriate drug combinations may achieve synergistic effects beyond monotherapies alone. AC220 (Quizartinib), an FLT3 receptor tyrosine kinase inhibitor, developed fo...
Saved in:
| Published in: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833862/ https://ncbi.nlm.nih.gov/pubmed/29374185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0170-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|